Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum ProMIS Neurosciences Inc PMN

ProMIS Neurosciences Inc. is a clinical-stage biotechnology company. It is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine applies a thermodynamic, computational... see more

NDAQ:PMN - Post Discussion

ProMIS Neurosciences Inc > Partnership
View:
Post by goldtech on Jun 27, 2024 11:43am

Partnership

They have been talking about partnerships for over 2 years and still can't get a deal done. This is one of two reasons, our management group is inept , or our science is mediocre, I tend to believe our management team are useless and are here for a paycheck only. If you partner then you don't need massive dilution and with cash upfront you can further the other antibodies. Our new CEO may be out of his league in this field and we need someone with industry contacts.
Comment by Speyeder999 on Jul 03, 2024 6:01pm
It's actually 6 years or more that they've beeen talking about partnerships. Not sure about the inept management or mediocre science though...either one can only take you so far. But quite frankly,  I do have to wonder about management's sincerity in getting a deal done in a timey fashion, unless of course they are going door to door peddling snake oil concoctions that no Pharma ...more  
Comment by FarmerBetsy on Jul 03, 2024 10:07pm
A lot to unpack here, but no question management has mislead long term investors for years.  Certainly have mislead about timeframes over the years, which is why they don't post past presentations  like other public companies, would just confirm investors findings. Maybe it's about the BOD chair getting  the company to go long enough to get his $225,000 for 3 years when they ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities